Hopp til innhold
Close

Get alerts of updates about «Hyperbaric oxygen therapy for osteonecrosis - project plan»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Hyperbaric oxygen therapy for osteonecrosis - project plan

Oops, something went wrong...

... contact nettredaksjon@fhi.no.

... reload the page and try again-

Project

Hyperbaric oxygen therapy for osteonecrosis - project plan - project description

Published

The Norwegian Institute of Public Health has been commissioned to assess the effects, safety and cost-effectiveness of hyperbaric oxygen therapy for osteonecrosis.


Summary

The Norwegian Institute of Public Health has been commissioned to assess the effects, safety and cost-effectiveness of hyperbaric oxygen therapy for osteonecrosis.

Osteonecrosis is a bone disease that can progress to collapse of bone structure in one or more joints. In severe cases, total joint replacement is often the only option that allows patients to resume normal activities. Hyperbaric oxygen therapy (HBOT) may be a joint preserving treatment option. HBOT involves inhaling pure oxygen under pressure. The aim of this health technology assessment is to assess the effects, safety and cost-effectiveness of hyperbaric oxygen therapy for osteonecrosis.

Project number

ID2017-088

Start

11.2017

End

11.2018

Status

Concluded

Principal institution

Project owner/ Project manager

Folkehelseinstituttet

Project manager

Hege Kornør

External participants

Bernd Mueller (Haukeland universitetssykehus), Ketil Spook (Oslo universitetssykehus), Geir Hallan (Haukeland universitetssykehus)